IMMUNE RESPONSE FOLLOWING REACTIVE VACCINATION CAMPAIGN USING FRACTIONAL DOSE YELLOW FEVER VACCINE - KINSHASA, DEMOCRATIC REPUBLIC OF CONGO, 2016

被引：0

作者：

Casey, Rebecca M. ^{[1
]}

Dixon, Meredith ^{[2
]}

Ahuka-Mundeke, Steve ^{[3
]}

Harris, Jennifer ^{[2
]}

Mbunsu, Kizito ^{[3
]}

Mutantu, Pierre ^{[3
]}

Laven, Janeen ^{[4
]}

Paluku, Gilson ^{[2
]}

Gueye, Abdou Salam ^{[5
]}

Hyde, Terri B. ^{[2
]}

Staples, J. Erin ^{[4
]}

Muyembe-Tamfum, Jean-Jacques ^{[3
]}

机构：

[1] Ctr Dis Control & Prevent, Global Immunizat Div, Epidem Intelligence Serv, Atlanta, GA USA

[2] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA USA

[3] Inst Natl Rech Biomed, Lab Virol, Kinshasa, DEM REP CONGO

[4] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA

[5] Ctr Dis Control & Prevent, Div Global Hlth Protect, Kinshasa, DEM REP CONGO

来源：

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 97卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

668

引用

页码：209 / 209

页数：1

共 27 条

[21] Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51
Dubischar-Kastner, Katrin
Eder, Susanne
Buerger, Vera
Gartner-Woelfl, Gabriele
Kaltenboeck, Astrid
Schuller, Elisabeth
Tauber, Erich
Klade, Christoph
[J]. VACCINE, 2010, 28 (32) : 5197 - 5202
[22] LONG-TERM IMMUNITY FOLLOWING VACCINATION WITH THE INACTIVATED JAPANESE ENCEPHALITIS VACCINE IXIARO®, IC51, AND IMMUNE RESPONSE TO A BOOSTER DOSE
Dubischar-Kastner, Katrin L.
Eder, Susanne
Kaltenboeck, Astrid
Klade, Christoph
Woelfl, Gabriele
[J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (05): : 325 - 325
[23] Assessment of the integrated disease surveillance and response system implementation in health zones at risk for viral hemorrhagic fever outbreaks in North Kivu, Democratic Republic of the Congo, following a major Ebola outbreak, 2021
Kallay, Ruth
Mbuyi, Gisele
Eggers, Carrie
Coulibaly, Soumaila
Kangoye, David Tiga
Kubuya, Janvier
Soke, Gnakub Norbert
Mossoko, Mathias
Kazambu, Ditu
Magazani, Alain
Fonjungo, Peter
Luce, Richard
Aruna, Aaron
[J]. BMC PUBLIC HEALTH, 2024, 24 (01)
[24] HUMORAL IMMUNE RESPONSE OF THE ADDITIONAL CHADOX1 NCOV-19 VACCINE FOLLOWING A TWO-DOSE INACTIVATED WHOLE-VIRUS SARS-COV-2 VACCINATION IN PATIENTS ON DIALYSIS
Kitpermkiat, Rungthiwa
Bruminhent, Jackrapong
Setthaudom, Chavachol
Chuengsaman, Piyatida
Kiertiburanakul, Sasisopin
Malathum, Kumthorn
Assanatham, Montira
Nongnuch, Arkom
Phuphuakrat, Angsana
Chaumdee, Pongsathon
Janphram, Chitimaporn
Thotsiri, Sansanee
Boongird, Sarinya
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I127 - I127
[25] Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020-Preliminary report
Casey, Rebecca M.
Najjengo, Marjorie Sserunga
Lubega, Irene
Sekiziyivu, Arthur B.
Twinomuhwezi-Oyet, Ellon
Nakato, Winfred Nansozi
Sciarratta, Courtney N.
Chu, Susan Y.
Doshi, Reena H.
Kambugu, Andrew
Gidudu, Jane F.
[J]. VACCINE, 2024, 42 (22)
[26] Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming
van der Velden, Maikel V. W.
Aichinger, Gerald
Poellabauer, Eva Maria
Loew-Baselli, Alexandra
Fritsch, Sandor
Benamara, Karima
Kistner, Otfried
Mueller, Markus
Zeitlinger, Markus
Kollaritsch, Herwig
Vesikari, Timo
Ehrlich, Hartmut J.
Barrett, P. Noel
[J]. VACCINE, 2012, 30 (43) : 6127 - 6135
[27] Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients
Davidovic, Tamara
Schimpf, Judith
Abbassi-Nik, Armin
Stockinger, Richard
Sprenger-Maehr, Hannelore
Lhotta, Karl
Zitt, Emanuel
[J]. FRONTIERS IN IMMUNOLOGY, 2022, 13

← 1 2 3 →